Vista Pharmaceuticals informs about closure of trading window

30 Mar 2021 Evaluate

In compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI (Prohibition of insider Trading) Regulations, 2015 as amended from time to time, Vista Pharmaceuticals has informed that the Company has intimated to all its Directors, Key Management Personnel and Designated Employees regarding the Closure of the Trading Window of the Company from 01/04/2021 till 48 hours from the conclusion of Board meeting in which the audited Financial result for the quarter and year ended 31.03.2021 will be approved. This closure of the Trading Window is occasioned by reason of the meeting of the Board of Directors of the Company, which will be held on or before 30.05.2021 to consider, approve and take on record the audited Financial Results of the Company for the quarter and year ended 31.03.2021. Accordingly, all the insiders (including directors, key managerial personnel and designated employees) and their immediate relatives are directed to take notice that in terms of the trading restrictions placed under above regulations, not to deal in shares of the Company during the period of closure of Trading Window as stated above.

The above information is a part of company’s filings submitted to BSE.

Vista Pharma Share Price

8.69 0.00 (0.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×